Analytical evaluation of an automated immunoassay for cardiac troponin I: The Vidas Troponin I assay

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 10, 2003, Pages 1363-1368

  Di Serio, Francesca ^a   Trerotoli, Paolo ^b   Serio, Gabriella ^b   Varraso, Lucia ^a   Pansini, Nicola ^a  

^a POLICLINICO   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Acute myocardial infarction: AMI; Analytical performance; Troponin I

Indexed keywords

BIOLOGICAL MARKER; HEPARIN; LITHIUM; TROPONIN I;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HEART MUSCLE INJURY; HUMAN; IMMUNOASSAY; IN VITRO STUDY; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; LITHIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; TEMPERATURE DEPENDENCE;

AUTOMATION; HUMANS; IMMUNOASSAY; MYOCARDIUM; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 0142028065     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.209     Document Type: Article

References (13)

1. Myocardial infarction redefined - a Consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36:959-69, Eur Heart J 2000; 21:1502-13.
2. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2002; 40:1366-74.
3. Panteghini M, Apple FS, Christenson RH, Dati F, Mair J, Wu HA. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999; 37:687-93.
4. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). IFCC Scientific Division Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 2001; 39:174-8.
5. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS guideline EP5-A. Wayne PA: NCCLS, February 1999.
6. National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative analytical methods; proposed guideline. NCCLS guideline EP6-A. Wayne PA: NCCLS, September 1986.
7. National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples; approved guideline. NCCLS guideline EP9-A. Wayne PA: NCCLS, December 1995.
8. Kim WJ, Laterza OF, Hock KG, Pierson-Perry JF, Kaminski DM, Mesguich M, et al. Performance of a revised cardiac troponin method that minimizes interferences from heterophilic antibodies. Clin Chem 2002; 48:1028-34.
9. Armitage P, Berry G. Statistical methods in medical research, publication limited. Oxford: Blackwell Scientific, 1994.
10. Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000 46:100-4.
11. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307-10.
12. Panteghini M. Recent approaches to the standardization of cardiac markers. Clin Chim Acta 2001; 311:19-25.
13. Panteghini M. The measurement of cardiac markers. Where should we focus? Am J Clin Pathol 2002; 118:354-61.